Tomas Deierborg Selected Research

Type I Tumor Necrosis Factor Receptors

1/2016

Genetic ablation of soluble tumor necrosis factor with preservation of membrane tumor necrosis factor is associated with neuroprotection after focal cerebral ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomas Deierborg Research Topics

Disease

15	Stroke (Strokes) 01/2022 - 03/2008
10	Infarction (Infarctions) 01/2022 - 03/2008
8	Inflammation (Inflammations) 01/2021 - 11/2014
7	Brain Ischemia (Cerebral Ischemia) 01/2016 - 02/2009
5	Alzheimer Disease (Alzheimer's Disease) 10/2021 - 04/2011
5	Parkinson Disease (Parkinson's Disease) 01/2021 - 08/2008
4	Ischemia 12/2016 - 06/2008
3	Neuroinflammatory Diseases 01/2022 - 01/2016
3	Ischemic Stroke 02/2017 - 01/2016
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2016 - 04/2011
2	Synucleinopathies 01/2021 - 11/2014
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 09/2020 - 10/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 06/2008
2	Necrosis 02/2017 - 01/2016
1	Brain Diseases (Brain Disorder) 01/2022
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 09/2020
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 09/2020
1	Out-of-Hospital Cardiac Arrest 01/2020
1	Heart Arrest (Cardiac Arrest) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Infections 01/2020
1	COVID-19 01/2020
1	Epilepsy (Aura) 12/2019
1	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 01/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Muscular Dystrophies (Muscular Dystrophy) 10/2017
1	Edema (Dropsy) 01/2017
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2017
1	Craniocerebral Trauma (Head Injury) 01/2017
1	Starvation 03/2016
1	Neuromyelitis Optica (Devic's Disease) 01/2016
1	Disease Progression 01/2016
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2016
1	Multiple Sclerosis 11/2015
1	Anhedonia 09/2015
1	Multiple System Atrophy 08/2015
1	Retinal Degeneration 05/2015
1	Gliosis 05/2015

Drug/Important Bio-Agent (IBA)

10	Galectin 3 (LGALS3)IBA 01/2022 - 04/2011
8	CytokinesIBA 01/2022 - 11/2015
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2008
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 02/2009
3	Amyloid beta-PeptidesIBA 10/2021 - 01/2019
3	Interleukin-6 (Interleukin 6)IBA 02/2017 - 01/2016
2	LipopolysaccharidesIBA 01/2021 - 03/2015
2	alpha-SynucleinIBA 01/2021 - 08/2015
2	GTP-Binding Proteins (G-Protein)IBA 01/2018 - 09/2014
2	Interleukin-2 (IL2)IBA 02/2017 - 01/2016
2	Neuroprotective AgentsIBA 05/2016 - 02/2009
2	Messenger RNA (mRNA)IBA 01/2016 - 03/2008
2	CaspasesIBA 01/2016 - 04/2011
2	Retinaldehyde (Retinal)IBA 01/2016 - 05/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 01/2016
2	Macrophage Migration-Inhibitory FactorsIBA 06/2011 - 04/2011
1	PrionsIBA 10/2021
1	Amyloid (Amyloid Fibrils)IBA 03/2021
1	MHC class II transactivator proteinIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Synapsins (Synapsin I)IBA 12/2019
1	Peptides (Polypeptides)IBA 01/2019
1	LigandsIBA 01/2019
1	pimonidazoleIBA 01/2018
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2018
1	Metformin (Glucophage)FDA LinkGeneric 01/2018
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2018
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2018
1	Laminin (Merosin)IBA 10/2017
1	OsteopontinIBA 10/2017
1	Interleukin-10 (Interleukin 10)IBA 02/2017
1	Interleukin-8 (Interleukin 8)IBA 02/2017
1	InterleukinsIBA 02/2017
1	Neutralizing AntibodiesIBA 01/2017
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2017
1	AlarminsIBA 01/2017
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2017
1	AcidsIBA 01/2017
1	FumaratesIBA 01/2017
1	CorticosteroneIBA 12/2016
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 05/2016
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 05/2016
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 03/2016
1	Protein Kinase InhibitorsIBA 03/2016
1	StaurosporineIBA 03/2016
1	Caspase 8 (Caspase-8)IBA 01/2016
1	Oxygen (Dioxygen)IBA 01/2016
1	ChemokinesIBA 01/2016
1	AutoantibodiesIBA 01/2016
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2016
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2016
1	Caspase 3 (Caspase-3)IBA 01/2016
1	InterferonsIBA 11/2015
1	Sucrose (Saccharose)IBA 09/2015
1	A-factor (Streptomyces)IBA 05/2015
1	XENP 1595IBA 12/2014
1	Etanercept (Enbrel)FDA Link 12/2014
1	Polymethyl Methacrylate (Sol)IBA 12/2014

Therapy/Procedure

6	Therapeutics 10/2017 - 08/2008
1	Injections 01/2021
1	Induced Hypothermia 01/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 05/2016